Conditions and diseases
Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis
Technology appraisal guidance [TA373]
16 December 2015
Tools and resources
Information for the public
Review and download supporting evidence. Includes the full guideline if available.